Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Steffensen

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Cancer Cell|July 16, 2015
Are Synthetic Compounds that Silence the Liver-X-Receptor the Next Generation of Anti-cancer Drugs?Knut R Steffensen
Ugeskrift for Laeger|October 7, 1991
[A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial]R Steffensen, E Sandøe
Scandinavian Journal of Immunology|January 11, 2012
Risk and prognosis of campylobacteriosis in relation to polymorphisms of host inflammatory cytokine genesH Nielsen, R Steffensen, T Ejlertsen
Journal of Immunological Methods|September 6, 2003
Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probesR Steffensen, K Hoffmann, K Varming
Tissue Antigens|March 1, 1991
Increased frequency of HLA-DRw14b(w6)-associated RFLP in Greenlanders of Eskimo originN Grunnet, R Steffensen, C Jersild
Diabetes|January 30, 2004
Putative metabolic effects of the liver X receptor (LXR)Knut R Steffensen, Jan-Ake Gustafsson
Tissue Antigens|November 5, 1998
Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primersR Steffensen, K Varming, C Jersild
Journal of the American College of Cardiology|March 25, 2000
The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)L Kjøller-Hansen, R Steffensen, P Grande
Journal of the American College of Cardiology|April 13, 2001
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failureL Kjøller-Hansen, R Steffensen, P Grande
Scandinavian Cardiovascular Journal : SCJ|November 5, 1998
The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experienceL Kjøller-Hansen, R Steffensen, P Grande
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Cancer Cell|July 16, 2015
Are Synthetic Compounds that Silence the Liver-X-Receptor the Next Generation of Anti-cancer Drugs?Knut R Steffensen
Ugeskrift for Laeger|October 7, 1991
[A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial]R Steffensen, E Sandøe
Scandinavian Journal of Immunology|January 11, 2012
Risk and prognosis of campylobacteriosis in relation to polymorphisms of host inflammatory cytokine genesH Nielsen, R Steffensen, T Ejlertsen
Journal of Immunological Methods|September 6, 2003
Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probesR Steffensen, K Hoffmann, K Varming
Tissue Antigens|March 1, 1991
Increased frequency of HLA-DRw14b(w6)-associated RFLP in Greenlanders of Eskimo originN Grunnet, R Steffensen, C Jersild
Diabetes|January 30, 2004
Putative metabolic effects of the liver X receptor (LXR)Knut R Steffensen, Jan-Ake Gustafsson
Tissue Antigens|November 5, 1998
Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primersR Steffensen, K Varming, C Jersild
Journal of the American College of Cardiology|March 25, 2000
The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)L Kjøller-Hansen, R Steffensen, P Grande
Journal of the American College of Cardiology|April 13, 2001
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failureL Kjøller-Hansen, R Steffensen, P Grande
Scandinavian Cardiovascular Journal : SCJ|November 5, 1998
The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experienceL Kjøller-Hansen, R Steffensen, P Grande
Pageof 17